S. Bughi, S. Fanchiang, B. Joyo, Richard Wong, A. Nazarian, Bryan Kakehashi, S. Shahinian, S. Desai, Paul Dillaway, T. Josic, Sylvia J. Shaw
{"title":"患者安全网络(PSN)报告低血糖","authors":"S. Bughi, S. Fanchiang, B. Joyo, Richard Wong, A. Nazarian, Bryan Kakehashi, S. Shahinian, S. Desai, Paul Dillaway, T. Josic, Sylvia J. Shaw","doi":"10.15344/2394-1502/2015/109","DOIUrl":null,"url":null,"abstract":"Hypoglycemia (hG) affects up to 26% of inpatients with diabetes mellitus (DM) and is responsible for an increase in cardiovascular morbidity and mortality. The goal of this pilot project (PP) was to decrease inpatient hG.","PeriodicalId":90866,"journal":{"name":"International journal of pharmaceutical sciences and research","volume":"17 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2015-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hypoglycemia Reported in Patient Safety Network (PSN)\",\"authors\":\"S. Bughi, S. Fanchiang, B. Joyo, Richard Wong, A. Nazarian, Bryan Kakehashi, S. Shahinian, S. Desai, Paul Dillaway, T. Josic, Sylvia J. Shaw\",\"doi\":\"10.15344/2394-1502/2015/109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hypoglycemia (hG) affects up to 26% of inpatients with diabetes mellitus (DM) and is responsible for an increase in cardiovascular morbidity and mortality. The goal of this pilot project (PP) was to decrease inpatient hG.\",\"PeriodicalId\":90866,\"journal\":{\"name\":\"International journal of pharmaceutical sciences and research\",\"volume\":\"17 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-08-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of pharmaceutical sciences and research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15344/2394-1502/2015/109\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pharmaceutical sciences and research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15344/2394-1502/2015/109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Hypoglycemia Reported in Patient Safety Network (PSN)
Hypoglycemia (hG) affects up to 26% of inpatients with diabetes mellitus (DM) and is responsible for an increase in cardiovascular morbidity and mortality. The goal of this pilot project (PP) was to decrease inpatient hG.